Nagi Bioscience SA

Founded in 2019, Nagi Bioscience is a spin-off of the Ecole Polytechnique Fédérale de Lausanne (EPFL) pioneering the alternative biological testing landscape for the past 10 years. With its innovative Organism-on-Chip technology, Nagi aims to revolutionize the way new substances are tested today through cutting-edge laboratory equipment that allows to unlock the full potential of small organisms for safety and efficacy assessment. Under the motto of in vivo testing at the in vitro scale, Nagi aims to drive transformative change within the biological testing sector, accelerating drug development pipelines and introducing new toxicology testing standards.